The Discounted Cash Flow (DCF) valuation of CureVac NV (CVAC) is (1.16) USD. With the latest stock price at 4.30 USD, the upside of CureVac NV based on DCF is -127.0%.
Based on the latest price of 4.30 USD and our DCF valuation, CureVac NV (CVAC) is a sell. selling CVAC stocks now will result in a potential gain of 127.0%.
Note: valuation result may not be accurate due to the company's negative cashflows.
| Range | Selected | |
| WACC / Discount Rate | 6.3% - 8.7% | 7.5% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | (6.63) - 0.07 | (1.16) |
| Upside | -254.3% - -98.4% | -127.0% |